Indication
Malignant neoplasm of the ovary
A malignant neoplasm of the ovary is a cancerous growth arising within one or both ovaries, which are vital components of the female reproductive and endocrine systems. Read more about Malignant neoplasm of the ovary
205 drugs 89 manufacturers
Drugs that treat it
Common Malignant neoplasm of the ovary therapies.
DOXIL (doxorubicin HCl pegylated liposomal)
TOPOTECAN (topotecan HCl)
LIPODOX (doxorubicin HCl pegylated liposomal)
LIPODOX 50 (doxorubicin HCl pegylated liposomal)
DOXORUBICIN HCL
DOXORUBICIN HCL
DOXORUBICIN HCL LIPOSOME (doxorubicin HCl pegylated liposomal)
TOPOTECAN HCL
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonA malignant neoplasm of the ovary is a cancerous growth arising within one or both ovaries, which are vital components of the female reproductive and endocrine systems.
The disease most commonly manifests in postmenopausal females as epithelial ovarian carcinoma, though it can also stem from germ cells or sex-cord stromal tissue.
Pathophysiologically, these malignancies involve abnormal cellular proliferation, genetic alterations such as BRCA variants, and aggressive local invasion with frequent transcoelomic dissemination across the peritoneal cavity.
Because early disease is frequently asymptomatic or presents with vague abdominal distension, bloating, and pelvic discomfort, most patients are diagnosed at advanced stages marked by extensive peritoneal metastases and malignant ascites.
- medlineplus.gov
A malignant neoplasm of the ovary is a cancerous growth arising within one or both ovaries, which are vital components of the female reproductive and endocrine systems Pathophysiologically, these malignancies involve abnormal cellular proliferation, genetic alterations such as BRCA variants, and aggressive local invasion with frequent transcoelomic dissemination across the peritoneal cavity
- medlineplus.gov
A malignant neoplasm of the ovary is a cancerous growth arising within one or both ovaries, which are vital components of the female reproductive and endocrine systems Pathophysiologically, these malignancies involve abnormal cellular proliferation, genetic alterations such as BRCA variants, and aggressive local invasion with frequent transcoelomic dissemination across the peritoneal cavity Because early disease is frequently asymptomatic or presents with vague abdominal distension, bloating, an...
- medlineplus.gov
The disease most commonly manifests in postmenopausal females as epithelial ovarian carcinoma, though it can also stem from germ cells or sex-cord stromal tissue
- nih.gov
The disease most commonly manifests in postmenopausal females as epithelial ovarian carcinoma, though it can also stem from germ cells or sex-cord stromal tissue
- americanpregnancy.org
Pathophysiologically, these malignancies involve abnormal cellular proliferation, genetic alterations such as BRCA variants, and aggressive local invasion with frequent transcoelomic dissemination across the peritoneal cavity Because early disease is frequently asymptomatic or presents with vague abdominal distension, bloating, and pelvic discomfort, most patients are diagnosed at advanced stages marked by extensive peritoneal metastases and malignant ascites
- medlineplus.gov
Because early disease is frequently asymptomatic or presents with vague abdominal distension, bloating, and pelvic discomfort, most patients are diagnosed at advanced stages marked by extensive peritoneal metastases and malignant ascites
Personalize your experience
Follow Malignant neoplasm of the ovary and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.